SEC Comment Letter for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA, TEVJF) (CIK 0000818686) (TEVA) — Oct 19, 2009

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA, TEVJF) (CIK 0000818686)
Date: Oct. 19, 2009 · CIK: 0000818686 · Accession: 0000000000-09-058777

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 000-16174

Date

October 19, 2009

Author

Gus Rodriguez

Form

UPLOAD

Company

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA, TEVJF) (CIK 0000818686)

Letter

Via Facsimile and U.S. Mail Mail Stop 4720 October 19, 2009 Mr. Eyal Desheh Chief Financial Officer Teva Pharmaceutical Industries Limited 5 Basel Street P.O. Box 3190 Petach Tikva 49131, Israel

Re: Teva Pharmaceutical Industries Limited Form 20-F for the Year Ended December 31, 2008 Filed February 27, 2009 Form 6-K filed May 7, 2009 File No. 000-16174

Dear Mr. Desheh:

We have completed our review of your Form 10-K and have no further comments at this time. Sincerely,

Gus Rodriguez Accounting Branch Chief

Show Raw Text

Via Facsimile and U.S. Mail Mail Stop 4720                                                                                                  October 19, 2009
Mr. Eyal Desheh Chief Financial Officer Teva Pharmaceutical Industries Limited 5 Basel Street  P.O. Box 3190  Petach Tikva 49131, Israel

Re: Teva Pharmaceutical Industries Limited
 Form 20-F for the Year Ended December 31, 2008  Filed February 27, 2009
 Form 6-K filed May 7, 2009
File No. 000-16174

Dear Mr. Desheh:

We have completed our review of your Form 10-K and have no further comments
at this time.
Sincerely,

Gus Rodriguez
Accounting Branch Chief

SecProbe.io